Equine Chorionic Gonadotropin (eCG) for Injection Market, Global Outlook and Forecast 2025-2032
Equine Chorionic Gonadotropin eCG for Injection Market Size, Share 2025
Report Overview
Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. The action of eCG is similar to the action of Follicle- Stimulating Hormone (FSH), which is produced by the animals' anterior pituitary gland. It stimulates the follicles of the ovaries to produce mature ova (eggs), and it promotes the outward signs of estrus (heat).
The global Equine Chorionic Gonadotropin (eCG) for Injection market size was estimated at USD 257 million in 2023 and is projected to reach USD 391.91 million by 2032, exhibiting a CAGR of 4.80% during the forecast period.
North America Equine Chorionic Gonadotropin (eCG) for Injection market size was estimated at USD 72.59 million in 2023, at a CAGR of 4.11% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Equine Chorionic Gonadotropin (eCG) for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Equine Chorionic Gonadotropin (eCG) for Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Equine Chorionic Gonadotropin (eCG) for Injection market in any manner.
Global Equine Chorionic Gonadotropin (eCG) for Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
MSD Animal Health
Ceva Sant� Animale
Syntex SA
Bioveta
Ningbo Sansheng Biological Technology
Ningbo Second Hormone Factory
Chifeng Bo-en Pharmaceutical
Guangzhou Vbio-Pharma
JALLY
Ningbo Creator Animal Pharmaceutical
Market Segmentation (by Type)
1000 IU/Unit
5000 IU/Unit
Others
Market Segmentation (by Application)
Pig
Cattle
Sheep
Horse
Other Animals
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414